- CA$971.21m
- CA$2.29bn
- CA$451.11m
- 51
- 44
- 78
- 59
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 43.8 | 65.5 | 209 | 475 | 451 |
Cost of Revenue | |||||
Gross Profit | 41.3 | 58.7 | 181 | 417 | 399 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 36.1 | 58.7 | 199 | 439 | 513 |
Operating Profit | 7.71 | 6.78 | 9.79 | 35.6 | -62 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.926 | -14.1 | -42.1 | 18.1 | -194 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.71 | -11.2 | -40.8 | 7.84 | -171 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.71 | -11.2 | -40.8 | 7.67 | -171 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 0.71 | -11.2 | -40.8 | -24.5 | -171 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.159 | -0.066 | -0.366 | 0.103 | -1.42 |
Dividends per Share |